Anti-respiratory syncytial virus monoclonal antibodies show promise in the treatment and prophylaxis of viral disease.
نویسندگان
چکیده
33 Waldrnann, H., Or, R., Hale, G., Weiss, L., Cividalli, G., Samuel, S., Manor, D., Brautbar, C., Polliack, A., Rachmilewitz, E. A. and Slavin, S. (1984) Lancet ii, 483-486 34 Hale, G., Cobbold, S. and Waldmann, H. (1988) Transplantation 45, 753-759 35 Hale, G. and Waldmann, H. for CAMPATH users (1994) Hernatotherapy 3, 15-31 36 Dyer, M. J. S., Hale, G., Hayhoe, F. G. J. and Waldrnann, H. (1989) Blood 73, 1431-1439 37 Friend, P. J., Waldrnann, H., Hale, G., Cobbold, S., Rebello, P., Thiru, S., Jarnieson, N. V., Johnston, P. S. and Calne, R. Y. (1991) Transplant Proc. 23,
منابع مشابه
Respiratory Syncytial Virus Infection in Children Referred to Kasra Hospital in Tehran during the Period of 2012-2014
Background and Aims: Respiratory syncytial virus (RSV) infection is common in infants and young children. In infants younger than one year old it may cause bronchiolitis and pneumonia which requires hospitalization. Accurate and rapid diagnosis of the disease will help proper treatment of the disease and prevent further complications. Materials and Methods: Specimen taken from respiratory ...
متن کاملAccurance of Respiratory Syncytial Virus Infection in Children Referred to Kasra Hospital Diagnostic Laboratory during 2009-2011
Background and Aims: Respiratory syncytial virus (RSV) infection is common in infants and young children. In infants younger than one year old it may cause bronchiolitis and pneumonia which requires hospitalization. Accurate and rapid diagnosis of the disease will help proper treatment of the disease and prevents further complications. Methods: Specimen taken from respiratory tract of sick chil...
متن کاملIntranasal Administration of Maleic Anhydride-Modified Human Serum Albumin for Pre-Exposure Prophylaxis of Respiratory Syncytial Virus Infection
Respiratory syncytial virus (RSV) is the leading cause of pediatric viral respiratory tract infections. Neither vaccine nor effective antiviral therapy is available to prevent and treat RSV infection. Palivizumab, a humanized monoclonal antibody, is the only product approved to prevent serious RSV infection, but its high cost is prohibitive in low-income countries. Here, we aimed to identify an...
متن کاملRespiratory Syncytial Virus Infection in Patients Referred to Kasra Hospital Laboratory during 2016-2019: A Continuous Study:
Abstract One of the main cause of severe respiratory infection in infants and young children is respiratory syncytial virus (RSV). The disease can also occur in adults and elderly individuals and clinically not to be differentiated from other viral respiratory infection. The disease causes bronchiolitis, and sometimes pneumonia in new born and young children which requires hospital care. To di...
متن کاملNeutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention.
Human respiratory syncytial virus (hRSV) is the most important viral agent of pediatric respiratory infections worldwide. The only specific treatment available today is a humanized monoclonal antibody (Palivizumab) directed against the F glycoprotein, administered prophylactically to children at very high risk of severe hRSV infections. Palivizumab, as most anti-F antibodies so far described, r...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Biochemical Society transactions
دوره 23 4 شماره
صفحات -
تاریخ انتشار 1995